Medicare Part B Inflation Rebate List Doubles For Third Quarter, Adds Several Amgen Drugs

 
• By Cathy Kelly

Amgen's Prolia appears to be the biggest drug on the list of products incurring price inflation penalties in Part B; many of the others have relatively low sales to Medicare.

Second List Of Drugs Subject To Price Inflation Rebates In Part B Released • Source: Shutterstock

More from Medicare

More from Government Payers